The global Flu (Influenza) Vaccine market was valued at US$ 5505 million in 2022 and is anticipated to reach US$ 7088.2 million by 2029, witnessing a CAGR of 3.6% during the forecast period 2023-2029.

Flu (Influenza) Vaccine Market

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.

In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).

Report Scope

This report aims to provide a comprehensive presentation of the global market for Flu (Influenza) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flu (Influenza) Vaccine.

The Flu (Influenza) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Flu (Influenza) Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Flu (Influenza) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Flu (Influenza) Vaccine Market Report

Report Metric	Details
Report Name	Flu (Influenza) Vaccine Market
Accounted market size in 2022	US$ 5505 in million
Forecasted market size in 2029	US$ 7088.2 million
CAGR	3.6%
Base Year	2022
Forecasted years	2023 - 2029
Segment by Type	Split Influenza Vaccine Pandemic Influenza Vaccine Subunit Influenza Vaccine Quadrivalent Influenza Vaccine
Segment by Application	For Children (6 months to 3 years) For Adults and Children over 3 years
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Hualan Bio, CCBIO, Aleph Biomedical, SANOFI, Adimmune, ZYAK, SINOVAC, Changsheng Biological, SIOBP, GSK, Aimei Hissen, Tianyuan Bio-pharma(Novartis), Simcere Vaxtec
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Flu (Influenza) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Flu (Influenza) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Flu (Influenza) Vaccine Market market growing?

Ans: The Flu (Influenza) Vaccine Market market witnessing a CAGR of 3.6% during the forecast period 2022-2029.

What is the Flu (Influenza) Vaccine Market market size in 2029?

Ans: The global Flu (Influenza) Vaccine market was valued at US$ 5505 million in 2022 and is anticipated to reach US$ 7088.2 million by 2029, witnessing a CAGR of 3.6% during the forecast period 2023-2029.

1 Flu (Influenza) Vaccine Market Overview

1.1 Product Overview and Scope of Flu (Influenza) Vaccine

1.2 Flu (Influenza) Vaccine Segment by Type

1.2.1 Global Flu (Influenza) Vaccine Market Value Comparison by Type (2023-2029)

1.2.2 Split Influenza Vaccine

1.2.3 Pandemic Influenza Vaccine

1.2.4 Subunit Influenza Vaccine

1.2.5 Quadrivalent Influenza Vaccine

1.3 Flu (Influenza) Vaccine Segment by Application

1.3.1 Global Flu (Influenza) Vaccine Market Value by Application: (2023-2029)

1.3.2 For Children (6 months to 3 years)

1.3.3 For Adults and Children over 3 years

1.4 Global Flu (Influenza) Vaccine Market Size Estimates and Forecasts

1.4.1 Global Flu (Influenza) Vaccine Revenue 2018-2029

1.4.2 Global Flu (Influenza) Vaccine Sales 2018-2029

1.4.3 Global Flu (Influenza) Vaccine Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2 Flu (Influenza) Vaccine Market Competition by Manufacturers

2.1 Global Flu (Influenza) Vaccine Sales Market Share by Manufacturers (2018-2023)

2.2 Global Flu (Influenza) Vaccine Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Flu (Influenza) Vaccine Average Price by Manufacturers (2018-2023)

2.4 Global Flu (Influenza) Vaccine Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Flu (Influenza) Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Flu (Influenza) Vaccine, Product Type & Application

2.7 Flu (Influenza) Vaccine Market Competitive Situation and Trends

2.7.1 Flu (Influenza) Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Flu (Influenza) Vaccine Players Market Share by Revenue

2.7.3 Global Flu (Influenza) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Flu (Influenza) Vaccine Retrospective Market Scenario by Region

3.1 Global Flu (Influenza) Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Flu (Influenza) Vaccine Global Flu (Influenza) Vaccine Sales by Region: 2018-2029

3.2.1 Global Flu (Influenza) Vaccine Sales by Region: 2018-2023

3.2.2 Global Flu (Influenza) Vaccine Sales by Region: 2024-2029

3.3 Global Flu (Influenza) Vaccine Global Flu (Influenza) Vaccine Revenue by Region: 2018-2029

3.3.1 Global Flu (Influenza) Vaccine Revenue by Region: 2018-2023

3.3.2 Global Flu (Influenza) Vaccine Revenue by Region: 2024-2029

3.4 North America Flu (Influenza) Vaccine Market Facts & Figures by Country

3.4.1 North America Flu (Influenza) Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Flu (Influenza) Vaccine Sales by Country (2018-2029)

3.4.3 North America Flu (Influenza) Vaccine Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Flu (Influenza) Vaccine Market Facts & Figures by Country

3.5.1 Europe Flu (Influenza) Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Flu (Influenza) Vaccine Sales by Country (2018-2029)

3.5.3 Europe Flu (Influenza) Vaccine Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Flu (Influenza) Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Flu (Influenza) Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Flu (Influenza) Vaccine Sales by Country (2018-2029)

3.6.3 Asia Pacific Flu (Influenza) Vaccine Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Flu (Influenza) Vaccine Market Facts & Figures by Country

3.7.1 Latin America Flu (Influenza) Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Flu (Influenza) Vaccine Sales by Country (2018-2029)

3.7.3 Latin America Flu (Influenza) Vaccine Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Flu (Influenza) Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Flu (Influenza) Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Flu (Influenza) Vaccine Sales by Country (2018-2029)

3.8.3 Middle East and Africa Flu (Influenza) Vaccine Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Flu (Influenza) Vaccine Sales by Type (2018-2029)

4.1.1 Global Flu (Influenza) Vaccine Sales by Type (2018-2023)

4.1.2 Global Flu (Influenza) Vaccine Sales by Type (2024-2029)

4.1.3 Global Flu (Influenza) Vaccine Sales Market Share by Type (2018-2029)

4.2 Global Flu (Influenza) Vaccine Revenue by Type (2018-2029)

4.2.1 Global Flu (Influenza) Vaccine Revenue by Type (2018-2023)

4.2.2 Global Flu (Influenza) Vaccine Revenue by Type (2024-2029)

4.2.3 Global Flu (Influenza) Vaccine Revenue Market Share by Type (2018-2029)

4.3 Global Flu (Influenza) Vaccine Price by Type (2018-2029)

5 Segment by Application

5.1 Global Flu (Influenza) Vaccine Sales by Application (2018-2029)

5.1.1 Global Flu (Influenza) Vaccine Sales by Application (2018-2023)

5.1.2 Global Flu (Influenza) Vaccine Sales by Application (2024-2029)

5.1.3 Global Flu (Influenza) Vaccine Sales Market Share by Application (2018-2029)

5.2 Global Flu (Influenza) Vaccine Revenue by Application (2018-2029)

5.2.1 Global Flu (Influenza) Vaccine Revenue by Application (2018-2023)

5.2.2 Global Flu (Influenza) Vaccine Revenue by Application (2024-2029)

5.2.3 Global Flu (Influenza) Vaccine Revenue Market Share by Application (2018-2029)

5.3 Global Flu (Influenza) Vaccine Price by Application (2018-2029)

6 Key Companies Profiled

6.1 Hualan Bio

6.1.1 Hualan Bio Corporation Information

6.1.2 Hualan Bio Description and Business Overview

6.1.3 Hualan Bio Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Hualan Bio Flu (Influenza) Vaccine Product Portfolio

6.1.5 Hualan Bio Recent Developments/Updates

6.2 CCBIO

6.2.1 CCBIO Corporation Information

6.2.2 CCBIO Description and Business Overview

6.2.3 CCBIO Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.2.4 CCBIO Flu (Influenza) Vaccine Product Portfolio

6.2.5 CCBIO Recent Developments/Updates

6.3 Aleph Biomedical

6.3.1 Aleph Biomedical Corporation Information

6.3.2 Aleph Biomedical Description and Business Overview

6.3.3 Aleph Biomedical Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Aleph Biomedical Flu (Influenza) Vaccine Product Portfolio

6.3.5 Aleph Biomedical Recent Developments/Updates

6.4 SANOFI

6.4.1 SANOFI Corporation Information

6.4.2 SANOFI Description and Business Overview

6.4.3 SANOFI Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 SANOFI Flu (Influenza) Vaccine Product Portfolio

6.4.5 SANOFI Recent Developments/Updates

6.5 Adimmune

6.5.1 Adimmune Corporation Information

6.5.2 Adimmune Description and Business Overview

6.5.3 Adimmune Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Adimmune Flu (Influenza) Vaccine Product Portfolio

6.5.5 Adimmune Recent Developments/Updates

6.6 ZYAK

6.6.1 ZYAK Corporation Information

6.6.2 ZYAK Description and Business Overview

6.6.3 ZYAK Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.6.4 ZYAK Flu (Influenza) Vaccine Product Portfolio

6.6.5 ZYAK Recent Developments/Updates

6.7 SINOVAC

6.6.1 SINOVAC Corporation Information

6.6.2 SINOVAC Description and Business Overview

6.6.3 SINOVAC Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 SINOVAC Flu (Influenza) Vaccine Product Portfolio

6.7.5 SINOVAC Recent Developments/Updates

6.8 Changsheng Biological

6.8.1 Changsheng Biological Corporation Information

6.8.2 Changsheng Biological Description and Business Overview

6.8.3 Changsheng Biological Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Changsheng Biological Flu (Influenza) Vaccine Product Portfolio

6.8.5 Changsheng Biological Recent Developments/Updates

6.9 SIOBP

6.9.1 SIOBP Corporation Information

6.9.2 SIOBP Description and Business Overview

6.9.3 SIOBP Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.9.4 SIOBP Flu (Influenza) Vaccine Product Portfolio

6.9.5 SIOBP Recent Developments/Updates

6.10 GSK

6.10.1 GSK Corporation Information

6.10.2 GSK Description and Business Overview

6.10.3 GSK Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.10.4 GSK Flu (Influenza) Vaccine Product Portfolio

6.10.5 GSK Recent Developments/Updates

6.11 Aimei Hissen

6.11.1 Aimei Hissen Corporation Information

6.11.2 Aimei Hissen Flu (Influenza) Vaccine Description and Business Overview

6.11.3 Aimei Hissen Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Aimei Hissen Flu (Influenza) Vaccine Product Portfolio

6.11.5 Aimei Hissen Recent Developments/Updates

6.12 Tianyuan Bio-pharma(Novartis)

6.12.1 Tianyuan Bio-pharma(Novartis) Corporation Information

6.12.2 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Description and Business Overview

6.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Portfolio

6.12.5 Tianyuan Bio-pharma(Novartis) Recent Developments/Updates

6.13 Simcere Vaxtec

6.13.1 Simcere Vaxtec Corporation Information

6.13.2 Simcere Vaxtec Flu (Influenza) Vaccine Description and Business Overview

6.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Simcere Vaxtec Flu (Influenza) Vaccine Product Portfolio

6.13.5 Simcere Vaxtec Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Flu (Influenza) Vaccine Industry Chain Analysis

7.2 Flu (Influenza) Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Flu (Influenza) Vaccine Production Mode & Process

7.4 Flu (Influenza) Vaccine Sales and Marketing

7.4.1 Flu (Influenza) Vaccine Sales Channels

7.4.2 Flu (Influenza) Vaccine Distributors

7.5 Flu (Influenza) Vaccine Customers

8 Flu (Influenza) Vaccine Market Dynamics

8.1 Flu (Influenza) Vaccine Industry Trends

8.2 Flu (Influenza) Vaccine Market Drivers

8.3 Flu (Influenza) Vaccine Market Challenges

8.4 Flu (Influenza) Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Changsheng Biological

SIOBP

GSK

Aimei Hissen

Tianyuan Bio-pharma(Novartis)

Simcere Vaxtec

List of Tables

Table 1. Global Flu (Influenza) Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

Table 2. Global Flu (Influenza) Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

Table 3. Global Flu (Influenza) Vaccine Market Competitive Situation by Manufacturers in 2022

Table 4. Global Flu (Influenza) Vaccine Sales (K Units) of Key Manufacturers (2018-2023)

Table 5. Global Flu (Influenza) Vaccine Sales Market Share by Manufacturers (2018-2023)

Table 6. Global Flu (Influenza) Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)

Table 7. Global Flu (Influenza) Vaccine Revenue Share by Manufacturers (2018-2023)

Table 8. Global Market Flu (Influenza) Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)

Table 9. Global Key Players of Flu (Influenza) Vaccine, Industry Ranking, 2021 VS 2022 VS 2023

Table 10. Global Key Manufacturers of Flu (Influenza) Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Flu (Influenza) Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Flu (Influenza) Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Flu (Influenza) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flu (Influenza) Vaccine as of 2022)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Flu (Influenza) Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 17. Global Flu (Influenza) Vaccine Sales by Region (2018-2023) & (K Units)

Table 18. Global Flu (Influenza) Vaccine Sales Market Share by Region (2018-2023)

Table 19. Global Flu (Influenza) Vaccine Sales by Region (2024-2029) & (K Units)

Table 20. Global Flu (Influenza) Vaccine Sales Market Share by Region (2024-2029)

Table 21. Global Flu (Influenza) Vaccine Revenue by Region (2018-2023) & (US$ Million)

Table 22. Global Flu (Influenza) Vaccine Revenue Market Share by Region (2018-2023)

Table 23. Global Flu (Influenza) Vaccine Revenue by Region (2024-2029) & (US$ Million)

Table 24. Global Flu (Influenza) Vaccine Revenue Market Share by Region (2024-2029)

Table 25. North America Flu (Influenza) Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 26. North America Flu (Influenza) Vaccine Sales by Country (2018-2023) & (K Units)

Table 27. North America Flu (Influenza) Vaccine Sales by Country (2024-2029) & (K Units)

Table 28. North America Flu (Influenza) Vaccine Revenue by Country (2018-2023) & (US$ Million)

Table 29. North America Flu (Influenza) Vaccine Revenue by Country (2024-2029) & (US$ Million)

Table 30. Europe Flu (Influenza) Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 31. Europe Flu (Influenza) Vaccine Sales by Country (2018-2023) & (K Units)

Table 32. Europe Flu (Influenza) Vaccine Sales by Country (2024-2029) & (K Units)

Table 33. Europe Flu (Influenza) Vaccine Revenue by Country (2018-2023) & (US$ Million)

Table 34. Europe Flu (Influenza) Vaccine Revenue by Country (2024-2029) & (US$ Million)

Table 35. Asia Pacific Flu (Influenza) Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 36. Asia Pacific Flu (Influenza) Vaccine Sales by Region (2018-2023) & (K Units)

Table 37. Asia Pacific Flu (Influenza) Vaccine Sales by Region (2024-2029) & (K Units)

Table 38. Asia Pacific Flu (Influenza) Vaccine Revenue by Region (2018-2023) & (US$ Million)

Table 39. Asia Pacific Flu (Influenza) Vaccine Revenue by Region (2024-2029) & (US$ Million)

Table 40. Latin America Flu (Influenza) Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 41. Latin America Flu (Influenza) Vaccine Sales by Country (2018-2023) & (K Units)

Table 42. Latin America Flu (Influenza) Vaccine Sales by Country (2024-2029) & (K Units)

Table 43. Latin America Flu (Influenza) Vaccine Revenue by Country (2018-2023) & (US$ Million)

Table 44. Latin America Flu (Influenza) Vaccine Revenue by Country (2024-2029) & (US$ Million)

Table 45. Middle East & Africa Flu (Influenza) Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 46. Middle East & Africa Flu (Influenza) Vaccine Sales by Country (2018-2023) & (K Units)

Table 47. Middle East & Africa Flu (Influenza) Vaccine Sales by Country (2024-2029) & (K Units)

Table 48. Middle East & Africa Flu (Influenza) Vaccine Revenue by Country (2018-2023) & (US$ Million)

Table 49. Middle East & Africa Flu (Influenza) Vaccine Revenue by Country (2024-2029) & (US$ Million)

Table 50. Global Flu (Influenza) Vaccine Sales (K Units) by Type (2018-2023)

Table 51. Global Flu (Influenza) Vaccine Sales (K Units) by Type (2024-2029)

Table 52. Global Flu (Influenza) Vaccine Sales Market Share by Type (2018-2023)

Table 53. Global Flu (Influenza) Vaccine Sales Market Share by Type (2024-2029)

Table 54. Global Flu (Influenza) Vaccine Revenue (US$ Million) by Type (2018-2023)

Table 55. Global Flu (Influenza) Vaccine Revenue (US$ Million) by Type (2024-2029)

Table 56. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2018-2023)

Table 57. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2024-2029)

Table 58. Global Flu (Influenza) Vaccine Price (US$/Unit) by Type (2018-2023)

Table 59. Global Flu (Influenza) Vaccine Price (US$/Unit) by Type (2024-2029)

Table 60. Global Flu (Influenza) Vaccine Sales (K Units) by Application (2018-2023)

Table 61. Global Flu (Influenza) Vaccine Sales (K Units) by Application (2024-2029)

Table 62. Global Flu (Influenza) Vaccine Sales Market Share by Application (2018-2023)

Table 63. Global Flu (Influenza) Vaccine Sales Market Share by Application (2024-2029)

Table 64. Global Flu (Influenza) Vaccine Revenue (US$ Million) by Application (2018-2023)

Table 65. Global Flu (Influenza) Vaccine Revenue (US$ Million) by Application (2024-2029)

Table 66. Global Flu (Influenza) Vaccine Revenue Market Share by Application (2018-2023)

Table 67. Global Flu (Influenza) Vaccine Revenue Market Share by Application (2024-2029)

Table 68. Global Flu (Influenza) Vaccine Price (US$/Unit) by Application (2018-2023)

Table 69. Global Flu (Influenza) Vaccine Price (US$/Unit) by Application (2024-2029)

Table 70. Hualan Bio Corporation Information

Table 71. Hualan Bio Description and Business Overview

Table 72. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 73. Hualan Bio Flu (Influenza) Vaccine Product

Table 74. Hualan Bio Recent Developments/Updates

Table 75. CCBIO Corporation Information

Table 76. CCBIO Description and Business Overview

Table 77. CCBIO Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 78. CCBIO Flu (Influenza) Vaccine Product

Table 79. CCBIO Recent Developments/Updates

Table 80. Aleph Biomedical Corporation Information

Table 81. Aleph Biomedical Description and Business Overview

Table 82. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 83. Aleph Biomedical Flu (Influenza) Vaccine Product

Table 84. Aleph Biomedical Recent Developments/Updates

Table 85. SANOFI Corporation Information

Table 86. SANOFI Description and Business Overview

Table 87. SANOFI Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 88. SANOFI Flu (Influenza) Vaccine Product

Table 89. SANOFI Recent Developments/Updates

Table 90. Adimmune Corporation Information

Table 91. Adimmune Description and Business Overview

Table 92. Adimmune Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 93. Adimmune Flu (Influenza) Vaccine Product

Table 94. Adimmune Recent Developments/Updates

Table 95. ZYAK Corporation Information

Table 96. ZYAK Description and Business Overview

Table 97. ZYAK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 98. ZYAK Flu (Influenza) Vaccine Product

Table 99. ZYAK Recent Developments/Updates

Table 100. SINOVAC Corporation Information

Table 101. SINOVAC Description and Business Overview

Table 102. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 103. SINOVAC Flu (Influenza) Vaccine Product

Table 104. SINOVAC Recent Developments/Updates

Table 105. Changsheng Biological Corporation Information

Table 106. Changsheng Biological Description and Business Overview

Table 107. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 108. Changsheng Biological Flu (Influenza) Vaccine Product

Table 109. Changsheng Biological Recent Developments/Updates

Table 110. SIOBP Corporation Information

Table 111. SIOBP Description and Business Overview

Table 112. SIOBP Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 113. SIOBP Flu (Influenza) Vaccine Product

Table 114. SIOBP Recent Developments/Updates

Table 115. GSK Corporation Information

Table 116. GSK Description and Business Overview

Table 117. GSK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 118. GSK Flu (Influenza) Vaccine Product

Table 119. GSK Recent Developments/Updates

Table 120. Aimei Hissen Corporation Information

Table 121. Aimei Hissen Description and Business Overview

Table 122. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 123. Aimei Hissen Flu (Influenza) Vaccine Product

Table 124. Aimei Hissen Recent Developments/Updates

Table 125. Tianyuan Bio-pharma(Novartis) Corporation Information

Table 126. Tianyuan Bio-pharma(Novartis) Description and Business Overview

Table 127. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 128. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product

Table 129. Tianyuan Bio-pharma(Novartis) Recent Developments/Updates

Table 130. Simcere Vaxtec Corporation Information

Table 131. Simcere Vaxtec Description and Business Overview

Table 132. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 133. Simcere Vaxtec Flu (Influenza) Vaccine Product

Table 134. Simcere Vaxtec Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Flu (Influenza) Vaccine Distributors List

Table 138. Flu (Influenza) Vaccine Customers List

Table 139. Flu (Influenza) Vaccine Market Trends

Table 140. Flu (Influenza) Vaccine Market Drivers

Table 141. Flu (Influenza) Vaccine Market Challenges

Table 142. Flu (Influenza) Vaccine Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Flu (Influenza) Vaccine

Figure 2. Global Flu (Influenza) Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

Figure 3. Global Flu (Influenza) Vaccine Market Share by Type in 2022 & 2029

Figure 4. Split Influenza Vaccine Product Picture

Figure 5. Pandemic Influenza Vaccine Product Picture

Figure 6. Subunit Influenza Vaccine Product Picture

Figure 7. Quadrivalent Influenza Vaccine Product Picture

Figure 8. Global Flu (Influenza) Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

Figure 9. Global Flu (Influenza) Vaccine Market Share by Application in 2022 & 2029

Figure 10. For Children (6 months to 3 years)

Figure 11. For Adults and Children over 3 years

Figure 12. Global Flu (Influenza) Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Flu (Influenza) Vaccine Market Size (2018-2029) & (US$ Million)

Figure 14. Global Flu (Influenza) Vaccine Sales (2018-2029) & (K Units)

Figure 15. Global Flu (Influenza) Vaccine Average Price (US$/Unit) & (2018-2029)

Figure 16. Flu (Influenza) Vaccine Report Years Considered

Figure 17. Flu (Influenza) Vaccine Sales Share by Manufacturers in 2022

Figure 18. Global Flu (Influenza) Vaccine Revenue Share by Manufacturers in 2022

Figure 19. The Global 5 and 10 Largest Flu (Influenza) Vaccine Players: Market Share by Revenue in 2022

Figure 20. Flu (Influenza) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 21. Global Flu (Influenza) Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Figure 22. North America Flu (Influenza) Vaccine Sales Market Share by Country (2018-2029)

Figure 23. North America Flu (Influenza) Vaccine Revenue Market Share by Country (2018-2029)

Figure 24. United States Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 25. Canada Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 26. Europe Flu (Influenza) Vaccine Sales Market Share by Country (2018-2029)

Figure 27. Europe Flu (Influenza) Vaccine Revenue Market Share by Country (2018-2029)

Figure 28. Germany Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 29. France Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 30. U.K. Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 31. Italy Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 32. Russia Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 33. Asia Pacific Flu (Influenza) Vaccine Sales Market Share by Region (2018-2029)

Figure 34. Asia Pacific Flu (Influenza) Vaccine Revenue Market Share by Region (2018-2029)

Figure 35. China Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 36. Japan Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 37. South Korea Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 38. India Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 39. Australia Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 40. China Taiwan Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 41. Indonesia Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 42. Thailand Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 43. Malaysia Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 44. Latin America Flu (Influenza) Vaccine Sales Market Share by Country (2018-2029)

Figure 45. Latin America Flu (Influenza) Vaccine Revenue Market Share by Country (2018-2029)

Figure 46. Mexico Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 47. Brazil Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 48. Argentina Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 49. Middle East & Africa Flu (Influenza) Vaccine Sales Market Share by Country (2018-2029)

Figure 50. Middle East & Africa Flu (Influenza) Vaccine Revenue Market Share by Country (2018-2029)

Figure 51. Turkey Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 52. Saudi Arabia Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 53. UAE Flu (Influenza) Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

Figure 54. Global Sales Market Share of Flu (Influenza) Vaccine by Type (2018-2029)

Figure 55. Global Revenue Market Share of Flu (Influenza) Vaccine by Type (2018-2029)

Figure 56. Global Flu (Influenza) Vaccine Price (US$/Unit) by Type (2018-2029)

Figure 57. Global Sales Market Share of Flu (Influenza) Vaccine by Application (2018-2029)

Figure 58. Global Revenue Market Share of Flu (Influenza) Vaccine by Application (2018-2029)

Figure 59. Global Flu (Influenza) Vaccine Price (US$/Unit) by Application (2018-2029)

Figure 60. Flu (Influenza) Vaccine Value Chain

Figure 61. Flu (Influenza) Vaccine Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Flu (Influenza) Vaccine Market Research Report 2023

Published Date: May 2023

Report Code: QYRE-Auto-23N7927

Global Flu (Influenza) Vaccine Market Research Report 2023

FEATURED COMPANIES

Flu (Influenza) Vaccine Market Size

Flu (Influenza) Vaccine Market

Report Scope

Scope of Flu (Influenza) Vaccine Market Report

Core Chapters

FAQ for this report

How fast is Flu (Influenza) Vaccine Market market growing?

What is the Flu (Influenza) Vaccine Market market size in 2029?

FEATURED COMPANIES